Should Routine Screening by Mammography be Replaced by a More Selective Service of Risk Assessment/Risk Management?

Women's Health

Volumn 6, Issue 1, 2010, Pages 71-76

  Baum, Michael ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

breast cancer; informed consent; overdiagnosis; risk management; screening

Indexed keywords

ARTICLE; BREAST TUMOR; FEMALE; HUMAN; MAMMOGRAPHY; NATIONAL HEALTH SERVICE; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; RISK MANAGEMENT; SENSITIVITY AND SPECIFICITY; STANDARD; UNITED KINGDOM;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GREAT BRITAIN; HUMANS; MAMMOGRAPHY; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; RISK MANAGEMENT; SENSITIVITY AND SPECIFICITY; STATE MEDICINE;

EID: 77951248355     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/WHE.09.70     Document Type: Article

References (27)

1. Papers of special note have been highlighted as:
2. of interest
3. of considerable interest
4. Welch HG Schwartz L Woloshin S: What's making us sick is an epidemic of diagnoses. In: The New York Times 2 January, 2007.
5. Gøtzsche PC Hartling OJ Nielsen M Brodersen J Jørgensen KJ: Breast screening: the facts - or maybe not. BMJ 338, 446–448 (2009).
6. Explains how women are denied the whole truth about the harms and benefits of screening and provides data on absolute numbers who might benefit, as well as those likely to be overtreated.
7. US Preventive Services Task Force: Screening for breast cancer: recommendations and rationale. Ann. Intern. Med 137, 344–346 (2002).
8. Independent support for the calculations used in [2].
9. Irwig L McCaffery K Salkeld G Bossuyt P: Screening and choice: informed choice for screening: implications for evaluation. BMJ 332, 1148–1150 (2006).
10. Zackrisson S Andersson I Manjer J Garne JP: Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow up study. BMJ 332, 689–692 (2006).
11. Transparent data on the rate of overdiagnosis of breast cancer in a screened cohort.
12. Welch HG: Should I be Tested for Cancer? Maybe Not and Here's Why. University of California Press, CA, USA (2004).
13. Excellent book for the intelligent layperson.
14. Zahl PH Strand BH Maehlen J: Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 328(7445), 921–924 (2004).
15. Jørgensen KJ Gøtzsche PC: Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 339, 2587–2590 (2009).
16. Welch HG: Overdiagnosis and mammography screening. BMJ 339, 1425 (2009).
17. Barry MJ: Screening for prostate cancer - the controversy that refuses to die. N. Engl. J. Med. 360(13) 1351–1354 (2009).
18. Schröder FH Hugosson J Roobol MJ et al.: Screening and prostate-cancer mortality in a randomized european study. N. Engl. J. Med. 360, 1320–1328 (2009).
19. Thornton H: Randomised clinical trials: the patient's point of view. In: Ductal Carcinoma In Situ of the Breast. Silverstein M (Ed.). Lippincott Williams & Wilkins, PA, USA (1997).
20. Davey C White V Ward JE: Insurance repercussions of mammographic screening: what do women think? Med. Sci. Monit. 8, LE54–LE55 (2003).
21. Forbes JF Cuzick J Buzdar A Howell A Tobias JS Baum M; Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group: Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol. 9(1), 45–53 (2008).
22. Evidence that with modern therapy the 5-year survival of breast cancer is approximately 90 %.
23. Clarke M Collins R Darby S et al.; Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503), 2087–2106 (2005).
24. Moss SM Cuckle H Evans A Johns L Waller M Bobrow L: Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow up: a randomised controlled trial. Lancet 368, 2053–2060 (2006).
25. Bunker JP Houghton J Baum M: Putting the risk of breast cancer in perspective. BMJ 317, 1307–1309 (1998).
26. Explains why we should not become obsessed with a single cause of death as 24 out of 25 women do not die of breast cancer.
27. Cummings SR Tice JA Bauer S et al.: Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J. Natl Cancer Inst. 101, 384–398 (2009).